WeVote
Log In

Bill

Bill

SB 274

Relating to: the membership of the Controlled Substances Board.

2025-2026 Regular Session Introduced by Jesse James

Wisconsin bill modifies Controlled Substances Board membership composition to reshape drug policy oversight and regulatory influence in the state.

Failed to pass pursuant to Senate Joint Resolution 1
0
WeVote Research Nonpartisan
Bill Summary · SB 274

Legislative bill overview

SB 274 modifies the composition and membership requirements of Wisconsin's Controlled Substances Board, a state agency that regulates controlled substance manufacturing, distribution, and use. The bill passed committee unanimously and is currently available for legislative scheduling, indicating broad initial support across party lines.

Why is this important

The Controlled Substances Board directly influences drug policy enforcement, medical cannabis access (if applicable), and pharmaceutical regulation in Wisconsin. Changes to board membership can shift priorities regarding criminal justice approaches, public health initiatives, and medical licensing decisions that affect thousands of residents and businesses.

Potential points of contention

  • Representation concerns: Changes to board composition may affect whose interests are prioritized—whether law enforcement, medical professionals, public health advocates, or business interests hold greater influence
  • Expertise requirements: Alterations to membership qualifications could either strengthen expert oversight or potentially weaken it depending on whether expertise standards are raised or lowered
  • Appointment authority: Modifications to how board members are selected or by whom could shift power between the governor, legislature, and existing board structures, raising separation-of-powers considerations

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.